33 studies found for:    " November 20, 2013":" December 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 20, 2013":" December 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients
Condition: HIV
Intervention: Drug: Tesamorelin
2 Completed Revealing Increased Axonal Loss in Treated HIV Patients
Condition: HIV Seropositivity
Intervention: Other: ophthalmologic examination and MRI
3 Active, not recruiting Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: ATV;   Drug: DRV;   Drug: Cobicistat;   Drug: BR
4 Completed Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: HIV Infection;   Monoclonal Antibody, Human;   HIV Antibodies;   VRC01 Monoclonal Antibody;   Neutralizing Antibody
Intervention: Drug: VRC-HIVMAB060-00-AB
5 Completed Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults
Conditions: HIV Infection;   Pneumococcal Infections
Intervention: Biological: pneumococcal conjugate 13 valent vaccine
6 Unknown  Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
7 Completed Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men
Conditions: HIV Infection;   Chlamydia;   Gonorrhea
Intervention:
8 Recruiting Evaluation of Enhanced Syphilis Screening Among HIV-positive Men
Condition: Syphilis
Intervention: Other: Syphilis testing with routine HIV bloodwork
9 Completed Optimizing Resilience and Coping in HIV Via Internet Delivery
Conditions: HIV Disease;   Depression;   Affect;   Psychological Stress
Intervention: Behavioral: Intervention
10 Unknown  Assessment of Group Peer Support to Children With HIV in Vietnam
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Behavioral: Enhanced Treatment Support (ETS)
11 Active, not recruiting A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS
Condition: HIV
Intervention: Behavioral: Peer Mentoring
12 Completed The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia
Condition: HIV Infection
Intervention: Other: Peer‐referral incentive program to increase VMMC uptake
13 Unknown  Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients
Conditions: Hepacivirus;   HIV Infections
Interventions: Drug: Pentoxifylline;   Drug: Placebo
14 Completed Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa
Condition: HIV
Interventions: Other: POC CD4 Testing;   Other: CD4 Referral;   Behavioral: Lay Counselor Follow-up;   Behavioral: Clinic Accompaniment;   Behavioral: Clinic Referral;   Behavioral: SMS Reminder;   Behavioral: Circumcision Promotion;   Other: POC VL;   Other: Laboratory based VL assay
15 Unknown  Systems Analysis and Improvement to Optimize pMTCT
Condition: HIV
Intervention: Other: pMTCT systems analysis and improvement
16 Active, not recruiting Niacin on Immune Activation : a Proof-of-concept Study
Condition: HIV
Intervention: Drug: Niacin
17 Completed A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
Conditions: Healthy;   HIV
Interventions: Biological: 1 mg/kg, single dose IV administration of 3BNC117;   Biological: 3 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, single dose IV administration of 3BNC117;   Biological: 30 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, two doses IV of 3BNC117;   Biological: 30 mg/kg, two doses IV of 3BNC117
18 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
19 Recruiting Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM
Conditions: Methamphetamine Abuse;   HIV
Interventions: Behavioral: Gay-specific, Theory-based Text Messages Transmitted by Peer Health Educators (TXT-PHE);   Behavioral: Gay-specific, Theory-based Text Messages Transmitted by Automation (TXT-Auto)
20 Unknown  Promoting Uptake and Retention of Option B+ in Malawi
Condition: HIV
Interventions: Other: Community based peer support;   Other: Facility-based Peer Support

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years